"This world-class team has extensive experience of working with industry to achieve commercial objectives.”
Have a read of this passage below taken from the original announcement with IMB...
Dr Gambin commented: We are looking forward to working with Phylogica on this exciting opportunity to commercialise such a unique product. The diversity of the Phylomer platform offers powerful advantages for development of a universal peptide-based biosensor. The potential applications of this technology are vast in healthcare, industrial and agricultural markets.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)